| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |